Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Norgine

More Like This

Medicine production expansion comes as Welsh Secretary announces new trade programme

PR Newswire associated0

Norgine Announces Appointment of New CEO Janneke van der Kamp

PR Newswire associated0

Norgine completes acquisition of Theravia

PR Newswire associated0

Norgine strengthens rare disease portfolio with acquisition of Theravia

PR Newswire associated0

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

PR Newswire associated0

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

PR Newswire associated0

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand